Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...
Edmond based Y ni.Fit, an FDA cleared bladder support device, is now sold at Walgreens in Oklahoma and Texas, expanding ...
ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...
Women who often munch fast food or packaged eats appear more likely to develop urinary incontinence, researchers recently ...
A phase II clinical trial found that combining radiotherapy with immune checkpoint inhibitors (durvalumab and tremelimumab) ...
The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...
GU ASCO annual meeting featured a session on the ABCs of antibody drug conjugates and a presentation by Dr. Di Maria Jiang discussing the targeting of bladder cancer with antibody drug conjugates. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback